15 Health Execs Reveal How They Stay Motivated
How do healthcare executives stay passionate about coming to work and keeping things positive and new? Managed Healthcare Executive asked 15 of them, and here’s what they said.
Read More
65 Is the New 45: Five Ways Seniors Can Reach Well-Being Goals
How to make Medicare Advantage plans attractive by meeting the needs of a new generation of senior patients.
What You Don’t Know About Remote Patient Monitoring
Five surprising updates about one of healthcare’s top trends.
PBM rebate solutions flawed, study says
A Commonwealth Fund study has revealing findings about PBMs’ use of rebates and impact on drug prices.
Pharm maker, PBMs lower insulin prices
How Technology is Addressing SDOH
How technologies are helping health systems think about-and mobilize on-social determinants of health.
The Future of the ACA
Healthcare experts weigh in on what we can expect in 2019 and beyond.
How Payers Are Keeping Specialty Drug Costs Down
The real-world strategies used to manage the high cost of specialty meds.
The State of Drug Rebates
The Trump Administration has taken a large interest in PBM drug rebates, which they say create higher drug prices. But do they?
Breast cancer drug now treats men
Metastatic breast cancer drug expands treatment to men.
11 Soft Skills Healthcare Executives Need to Succeed
Technical skills aren’t enough to effectively manage an organization-you need other skills they don’t teach in school.
Team Approach Offers Hope of Increasing Diabetes Treatment Compliance
A complex disease such as diabetes requires a team-based approach to help patients comply with their regimen.
Featured Exec Scott Rissmiller, MD: Chief Physician Executive at Atrium Health
After his mother’s journey with breast cancer, Scott Rissmiller discovered the deep desire to make an impact in others’ lives as a physician-leader.
Four Ways Health Execs Can Engage Providers
While it is difficult work, provider engagement is attainable. Here are some strategies that health systems can use to successfully engage their physicians.
The Forces Driving Specialty Drug Spending
What health execs need to know about the drugs and policies affecting spending.
Five Ways Diabetes Treatments are Changing
The disease management and insurer initiatives changing the diabetes landscape.
Lack of insulin competition high priority for FDA
FDA fast-tracks biosimiliar insulin products to elevate competition.
The Fight to End Misleading Info on Biosimilars
Industry groups are calling for clear FDA guidance on language used by biologic originators to protect market share.
The Promise of Specialty Drugs
What the future of specialty drugs holds for healthcare.
The Promises and Challenges of Gene Therapy
Gene therapy offers great hope for patients, but comes with a bevy of challenges for patients and payers alike.
New oral drugs treat MS
FDA approved 2 new multiple sclerosis drugs. Here's what you should know about them.
Are Drug Rebates Going Away?
A new HHS proposal could do away with-or at least forever change-PBM drug rebates. Here’s what that could mean for health execs.
OTC Meds Save Billions
How over-the-counter meds keep patients healthier.
Top Barriers to Population Health
A new study has revealing findings about the progress on population health objectives.
Most Hospitals Miss Out on Millions in Supply Chain Management Savings
The mistakes hospitals are making-and what they can do.
Why Some Groups Want to Kill Medicare for All
While the Democratic House and Democratic presidential candidates tout Medicare for All, opposing forces are also at work.
How One Health Plan Is Successfully Addressing SDOH
The tools and processes one of the largest not-for-profit Medicare Advantage plans uses to help seniors.
New postpartum drug comes at a high price
Postpartum drug is a game changer, but can women afford it?
FDA announces 3 big drug recalls
Several companies are recalling products due to contamination from substances such as carcinogens and glass-here’s what you should know.
Patient Control Over Health Data: Experts React
The ONC and CMS medical information transparency rule for patients, providers, and insurers may be the biggest change in healthcare system operations since the ACA. Here’s what to expect.
